SCHEMBL7757908

SCHEMBL7757908

O=C(O)N1CN(c2ccccc2)C2(CCNCC2)C1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.54
BDKRB2 P30411 1/20 0.44
NPC1L1 Q9UHC9 2/20 0.41
OPRM1 P35372 9/20 0.40
OPRD1 P41143 9/20 0.40
OPRK1 P41145 9/20 0.40
OPRL1 P41146 9/20 0.40
TSHR P16473 2/20 0.40
CYP2D6 P10635 2/20 0.39
USP2 O75604 2/20 0.39
DDR1 Q08345 1/20 0.38
DRD2 P14416 1/20 0.38
DRD4 P21917 1/20 0.38
HTR2A P28223 1/20 0.38
DRD3 P35462 1/20 0.38
MEN1 O00255 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
KMT2A Q03164 1/20 0.37
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20187016 0.84 HSD17B10 (0.57) HSD17B10BDKRB2NPC1L1OPRM1OPRD1
SCHEMBL173699 0.80 BDKRB2 (0.59) HSD17B10BDKRB2NPC1L1OPRM1OPRD1
SCHEMBL3067132 0.79 OPRL1 (0.61) HSD17B10BDKRB2NPC1L1OPRM1OPRD1
SCHEMBL1415422 0.79 HSD17B10 (0.52) HSD17B10BDKRB2NPC1L1OPRM1OPRD1
SCHEMBL319018 0.79 DDR1 (0.49) HSD17B10BDKRB2NPC1L1OPRD1TSHR
Hydrochloric Acid SCHEMBL3231229 0.78 OPRL1 (0.60) HSD17B10BDKRB2NPC1L1OPRM1OPRD1
Hydrochloric Acid SCHEMBL9485290 0.78 OPRL1 (0.60) HSD17B10BDKRB2NPC1L1OPRM1OPRD1
SCHEMBL12893390 0.78 BDKRB2 (0.74) HSD17B10BDKRB2NPC1L1OPRM1OPRD1
SCHEMBL1415418 0.77 HSD17B10 (0.54) HSD17B10BDKRB2NPC1L1OPRM1OPRD1
Trifluoroacetic Acid SCHEMBL6247355 0.77 OPRM1 (0.52) HSD17B10BDKRB2NPC1L1OPRM1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6277991-B1 FOR TREATMENT OF MIGRAINE, NON-INSULIN DEPENDENT DIABETES MELLITUS, SEPSIS, INFLAMMATION, INCONTINENCE, VASOMOTOR DISTURBANCES SUCH AS HOT FLUSHES OR HOT FLASHES NOVO NORDISK A/S (DK) 2001-08-21 US disclosed
EP-1080091-A1 NOVEL 1,3,8-TRIAZASPIRO[4.5]DECANONES WITH HIGH AFFINITY FOR OPIOID RECEPTOR SUBTYPES Novo Nordisk A/S (DK) 2001-03-07 EP disclosed
WO-1999059997-A1 NOVEL 1,3,8-TRIAZASPIRO[4.5]DECANONES WITH HIGH AFFINITY FOR OPIOID RECEPTOR SUBTYPES NOVO NORDISK A/S (DK) 1999-11-25 WO disclosed